BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 1, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Feb. 20, 2020

Feb. 20, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Oncotherapy, Allergan, Btl Industries, Cantel Medical, CMR Surgical, Cybermdx, Edmund Optics, Endonovo Therapeutics, Hu-Friedy, Icon, Inomec, Integer Holdings, Medpass International, Lantheus Holdings, Legion Healthcare Partners, Lexagene Holdings, Lexington Biosciences, Lucid Diagnostics, Medhub, Medlever, Moleculight, Neovasc, Pavmed, Progenics Pharmaceuticals.
Read More

Financings for Feb. 20, 2020

Feb. 20, 2020
Med-tech firms raising money in public or private financings, including: Bausch Health Companies, Catalent, Cloudbreak Health, Q Bio.
Read More

Appointments and advancements for Feb. 20, 2020

Feb. 20, 2020
New hires and promotions in the med-tech industry, including: Beta Bionics, Heart Vista, Sophia Genetics.
Read More

Regulatory actions for Feb. 20, 2020

Feb. 20, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adial, Forma, Heron .
Read More

Other news to note for Feb. 20, 2020

Feb. 20, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bonus Biogroup, Cytokinetics, Dermira, Forte, Fresenius, FSD, Hemogenyx, Hepion, Hummingbird, Lantheus, Lilly, Mesoblast, Molecular Templates, Mycenax, Novan, Progenics, Recordati, Restorbio, Stonewise, Tocagen, Vifor, Wize, Xbiotech.
Read More

In the clinic for Feb. 20, 2020

Feb. 20, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaxis, Agenus, Axsome, Breath, Brickell, Compugen, Cyclo, Dyve, Galderma, Index, Magenta, Moleculin, Polyphor, Teva, Vascular Biogenics, Vistagen, Zambon.
Read More

Financings for Feb. 20, 2020

Feb. 20, 2020
Biopharmas raising money in public or private financings, including: Aeterna Zentaris, Alladapt, Axovant, Bioxcel, Deciphera, Hemostemix, Spruce.
Read More

Appointments and advancements for Feb. 20, 2020

Feb. 20, 2020
New hires and promotions in the biopharma industry, including: Askbio, Galectin, Kane, Vivera.
Read More

Regulatory actions for Feb. 19, 2020

Feb. 19, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Canon Medical Systems USA, Conavi Medical, Endoclot Plus, Flowonix Medical.
Read More

In the clinic for Feb. 19, 2020

Feb. 19, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: BBS-Bioactive Bone Substitutes, Nantomics, Nanthealth.
Read More
Previous 1 2 … 1614 1615 1616 1617 1618 1619 1620 1621 1622 … 1726 1727 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing